Estamos no ar no !
Saiba mais
Insulet
Sobre: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Funcionários: 5.400
Notícias
Positivo
Neutro
Negativo
Sentimento
3 meses
Positivo
5,8%
Neutro
92,3%
Negativo
1,9%
Gráficos de preços implementados com Lightweight Charts™